Companies: 10,638     total market cap: $135.472 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sarepta Therapeutics
SRPT
#4401
Rank
$2.33 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$22.26
Share price
-2.45%
Change (1 day)
-82.37%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $2.17 Billion USD

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are $2.17 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$2.43 B1.26%
2023-12-31$2.40 B-12.33%
2022-12-31$2.74 B23.58%
2021-12-31$2.21 B-0.13%
2020-12-31$2.22 B121.27%
2019-12-31$1.00 B64.75%
2018-12-31$0.60 B17.55%
2017-12-31$0.51 B493.44%
2016-12-31$87.41 M4.77%
2015-12-31$83.43 M76.1%
2014-12-31$47.38 M6.77%
2013-12-31$44.37 M-45.43%
2012-12-31$81.31 M248.22%
2011-12-31$23.35 M-52.14%
2010-12-31$48.79 M34.06%
2009-12-31$36.39 M271.25%
2008-12-31$9.8 M-20.01%
2007-12-31$12.25 M288.98%
2006-12-31$3.15 M14.66%
2005-12-31$2.74 M22.15%
2004-12-31$2.24 M-40.03%
2003-12-31$3.75 M-26.77%
2002-12-31$5.12 M56.11%
2001-12-31$3.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
$37.07 B 1,606.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.33 B-38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
$0.24 B-88.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.83 B-61.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$4.61 B 112.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
$2.79 B 28.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
$1.41 B-34.88%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com